Barclays PLC Champions Oncology, Inc. Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$7.21 - $9.47 $9,675 - $12,708	1,342 New	1,342 $10,000
Q4 2021 Feb 14, 2022	SELL	$7.76 - $10.23 $6,347 - $8,368	-818 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$9.11 - $10.96 $255 - $306	-28 Reduced 3.31%	818 $8,000
Q2 2021 Aug 13, 2021	SELL	$8.45 - $11.72 $40,661 - $56,396	-4,812 Reduced 85.05%	846 $9,000
Q1 2021 May 13, 2021	BUY	$10.61 - $13.75 $37,941 - $49,170	3,576 Added 171.76%	5,658 $64,000
Q4 2020 Feb 11, 2021	SELL	$8.39 - $13.27 $9,866 - $15,605	-1,176 Reduced 36.1%	2,082 $22,000
Q3 2020 Nov 12, 2020	SELL	$7.05 - $10.2 $5,097 - $7,374	-723 Reduced 18.16%	3,258 $30,000
Q2 2020 Aug 12, 2020	BUY	$6.65 - $9.84 $26,473 - $39,173	3,981 New	3,981 $38,000
Q2 2019 Aug 14, 2019	SELL	$7.51 - $10.12 $352 - $475	-47 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.89 - $12.23 $370 - $574	47 New	47 $0

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.